Advertisement

Johnson & Johnson Says It Could Have 20 Million Single-Dose Vaccine Units By End Of March15:18
Download

Play

It's a big week for the Johnson & Johnson coronavirus vaccine. The FDA deemed it safe and effective today, and it appears to be more effective than originally reported against the newer, more infectious variants of the coronavirus. That brings the vaccine a critical step closer to being authorized for emergency use. Johnson and Johnson says it could have 20 million units of its single-dose vaccine available by the end of March.

We speak about what this means with Dr. Dan Barouch, the director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center. His lab helped design the Johnson & Johnson vaccine. We also speak with WBUR's Carey Goldberg, one last time, about the latest vaccine and coronavirus news.

This segment aired on February 24, 2021.

Paris Alston Twitter Producer, Radio Boston
Paris Alston is a producer for Radio Boston and WBUR's host of the Consider This podcast.

More…

Carey Goldberg Twitter Editor, CommonHealth
Carey Goldberg is the editor of WBUR's CommonHealth section.

More…

Tiziana Dearing Twitter Host, Radio Boston
Tiziana Dearing is the host of Radio Boston.

More…

Advertisement

Advertisement